Diabetes

A recent analysis examined whether butter consumption was associated with all-cause mortality, cardiovascular disease, and diabetes.

A recent study explored the excess risk of death associated with diabetes among patients with ST-elevation myocardial infarction.

A recent study compared the effectiveness of 3 methods of nutrition therapy for weight loss and hemoglobin A1c level reduction in a population of overweight or obese adults with type 2 diabetes.

A recent analysis assessed the impact of nonfatal cardiovascular events on mortality rates in patients with type 2 diabetes.

The FDA strengthened its warning of kidney injury in patients with type 2 diabetes taking 2 SGLT2 inhibitors.

A new study examined the association between several varieties of healthful and unhealthful plant-based diets on the risk of developing type 2 diabetes.

A recent trial assessed the cardiovascular effects of liraglutide, a glucagon-like peptide 1 analogue, when used in addition to standard treatment in patients with type 2 diabetes.

The neuroprotective potential of long-term metformin treatment was evaluated in a recent study.

New research investigated the prevalence of intensive treatment among patients with type 2 diabetes who do not use insulin and how it affected the risk of severe hypoglycemia.

A recent analysis compared the effect of canagliflozin and glimepiride on HbA1c reduction in patients with type 2 diabetes on background metformin.